Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf to Envarsus switch study in kidney transplant recipients with low tacrolimus C/D ratio
NL-OMON54135Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2022
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus in Kidney allograft status (RTx), sponsored by Amsterdam University Medical Center. Primary endpoint: Tacrolimus LCPT dose required to achieve therapeutic trough levels. Started Feb 2022; status: recruiting.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on NL-OMON54135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54135.